Cytek Biosciences Inc
(NAS:CTKB)
$
6.39
-0.14 (-2.14%)
Market Cap: 841.13 Mil
Enterprise Value: 572.72 Mil
PE Ratio: 0
PB Ratio: 2.20
GF Score: 60/100 Cytek Biosciences Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 27, 2023 / 05:15PM GMT
Release Date Price:
$6.18
(-2.52%)
Ross Osborn Cantor Fitzgerald;Analyst
Good afternoon, my name is Ross Osborn, I'm the MedTech, life science tools, and diagnostics analyst at Cantor. And today we have the honor of hosting Cytek Biosciences, including the CEO, Wenbin Jiang; and Patrik Jeanmonod. Apologies for the pronunciation.
But turning off, would you just provide a brief a brief background on yourselves.
Wenbin Jiang Cytek Biosciences
Inc. - CEO & Chairman of the Board
Thank you, Ross. I'm Wenbin Jiang, CEO and the Co-Founder of Cytek. And the company was founded 8.5 years ago and has been an exciting journey, and the company went public in '21.
Ross Osborn Cantor Fitzgerald;Analyst
Great.
Patrik Jeanmonod Cytek Biosciences;Ross
Inc. - CFO
And I'm Patrik Jeanmonod, I'm the CFO. I joined Cytek in 2018. I have about 20 plus years in life science industry experience working for PE-backed, VC-backed, family owned organization, early stage and late stage.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot